Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131871 · ClinicalTrials.gov registry record · Phase 2
Innovative Approaches to Diet, Exercise and Activity
A Phase 2 study of Body Weight, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 471
- Enrollment target
- 1
- Study location
NCT01131871: Completed Phase 2 study of Body Weight, sponsored by University of Pittsburgh.
NCT01131871 is a Phase 2 study of Body Weight that has completed, run by University of Pittsburgh. The registered enrollment target is 471 participants, above the 264-participant average among 23 other Body Weight trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01131871, a Phase 2 study of Body Weight, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 471 participants
- Enrollment target
- 1
- Study location
Study Summary
The prevalence of obesity in young adults has been increasing, and excessive body weight have been linked to numerous chronic conditions including cardiovascular disease, diabetes, many forms of cancer, and numerous musculoskeletal problems. This study will focus of the development and evaluation of interventions that may be appropriate for young adults (age 18-35 years) to improve weight loss outcomes following a 24 month intervention. The primary aim of this study is to examine whether an enhanced weight loss intervention (EWLI) that includes technology components results in improved weight loss in young adults (18-35 years of age) compared to a standard behavioral weight loss intervention (SBWP) over a period of 24 months. Eligible participants will also be assessed for body composition, body fat distribution, fitness, physical activity, dietary intake, and behavioral/psychosocial measures that may be predictive of behavior change. Assessments will occur at 0, 6, 12, 18, and 24 months. Subjects will participate in a 24 month behavioral weight loss program that includes a reduction in energy intake and moderate-to-vigorous intensity exercise (progressively increasing from 100 to 300 minutes per week). The technologies added to EWLI are text messaging, a wearable device that provides feedback on physical activity, and access to a website to monitor dietary behaviors.
Primary Outcome
Body weight will be assessed on a digital scale to assess change in body weight over the 24 month intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Standard Behavioral Weight Loss Intervention
- BEHAVIORAL Enhanced Weight Loss Intervention
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
What the finished NCT01131871 record still lists
NCT01131871 is an interventional study that assigns participants to a tested intervention. The registered 471 participants enrollment target is mid-sized for trials with a published cap, above the 264-participant average among 23 other Body Weight trials with a reported enrollment target (78% higher).
The record links to 1 condition, with Body Weight appearing as the primary indexed condition, and to 2 interventions - of which Standard Behavioral Weight Loss Intervention is the first listed.
NCT01131871 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01131871 about?
NCT01131871 is a clinical study titled "Innovative Approaches to Diet, Exercise and Activity". The prevalence of obesity in young adults has been increasing, and excessive body weight have been linked to numerous chronic conditions including cardiovascular disease, diabetes, many forms of cancer, and numerous musculoskeletal problems. This study will focus of the development and evaluation of...
What is the current status of trial NCT01131871?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 471 participants. The study started on 2010-09. Estimated completion is 2014-11.
What conditions does trial NCT01131871 study?
This clinical trial studies the following conditions: Body Weight.
What interventions are being tested in trial NCT01131871?
The interventions under investigation include: Standard Behavioral Weight Loss Intervention (BEHAVIORAL), Enhanced Weight Loss Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01131871?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01131871 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Weight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01131871's enrollment target sits among peer trials
471 3rd of 23 higher than 21 of 23 other Body Weight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Weight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diet-Induced Changes in GEnetic Material
RECRUITING
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial
RECRUITING · NA
-
Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans
RECRUITING · NA
-
Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation
RECRUITING · NA
-
Impact of Bright Light Therapy on Prader-Willi Syndrome
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
- NCT05201404 · 471 participants · Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia